Alembic's revenues down 3% as API exports slide
This article was originally published in Scrip
Executive Summary
Alembic of India has reported a 3% decline in sales to Rs2.83 billion ($60.9 million) for the quarter ended 30 June, hit by a slide in exports of active pharmaceutical ingredients (APIs). Net profits for the quarter declined to Rs114.8 million compared with Rs122.5 million in the corresponding quarter of the previous fiscal year.